Janssen hands back rights to imetelstat
admin 27th September 2018 Uncategorised 0Janssen Biotech has decided to terminate a collaboration and license agreement with Geron Corp for experimental cancer drug imetelstat.
More: Janssen hands back rights to imetelstat
Source: News